论文部分内容阅读
许多证据表明 ,实体瘤的生长和转移是依赖血管生成的。抗血管生成治疗恶性肿瘤是近年研究的新方向。这一新策略是以肿瘤间质为治疗的靶。本文介绍了这一策略的相关理论 ,发展状况及临床应用前景。
Many evidences indicate that the growth and metastasis of solid tumors are dependent on angiogenesis. Antiangiogenic therapy for malignant tumors is a new direction in recent research. This new strategy is a target for the treatment of tumor stroma. This article describes the relevant theories of this strategy, development status and clinical application prospects.